what is radioiodine-refractory dtc?
Published 4 years ago • 118 plays • Length 5:27Download video MP4
Download video MP3
Similar videos
-
2:02
radioiodine-refractory dtc: nccn guidelines
-
3:02
defining radioiodine-refractory dtc
-
57:02
redifferentiation of radioiodine refractory differentiated thyroid cancer
-
55:43
cabozantinib for radioiodine-refractory differentiated thyroid cancer with dr. sherman
-
6:02
introduction: treating rai-refractory differentiated thyroid cancer
-
5:58
role of the endocrinologist in rai-refractory thyroid cancer
-
4:33
molecular testing for rai-refractory thyroid cancer
-
8:01
systemic therapy for rai-refractory dtc
-
34:22
radioactive iodine (rai) therapy for rai-refractory disease: “redifferentiation” with dr. sherman
-
4:16
treatment options for rai-refractory differentiated thyroid cancer
-
4:34
initial management of rr-dtc
-
1:59
dr. marcia brose describes sorafenib in rai-resistant differentiated thyroid cancer
-
6:05
determining treatment for rai-refractory thyroid cancer
-
4:09
cosmic-311: cabozantinib versus placebo in patients with radioiodine-refractory differentiated t...
-
1:20
dr. michael tuttle on dosimetry versus empiric dosing radioactive iodine treatment
-
59:15
rai therapy and rai refractory non avid, rai resistant disease with dr ryder 332
-
1:20
dr. michael tuttle on dosimetry versus empiric dosing radioactive iodine treatment
-
57:15
212 drugs in development for rai-refractory differentiated thyroid cancer. new molecular targets
-
20:02
management of differentiated thyroid carcinoma in the era of targeted therapy